Loredana Vecchione

Berlin, BE 10117, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Liquid biopsy-based detection of acquired MET resistance enables sequential targeted therapy in MET fusion-positive NSCLC.

Liquid biopsy-based detection of acquired MET resistance enables sequential targeted therapy in MET fusion-positive NSCLC.

Journal: The oncologist
Published: February 13, 2026

The basis for future personalized therapy approaches - Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pancreatic cancer patients.

The basis for future personalized therapy approaches - Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pancreatic cancer patients.

Journal: European journal of cancer (Oxford, England : 1990)
Published: November 23, 2025

BRAFV600E patient derived colon cancer organoids identify biomarkers of response to EGFR and BRAF inhibition and replicate clinical data.

BRAFV600E patient derived colon cancer organoids identify biomarkers of response to EGFR and BRAF inhibition and replicate clinical data.

Journal: Journal of experimental & clinical cancer research : CR
Published: November 02, 2025

Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Study.

Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Study.

Journal: Cancer medicine
Published: September 12, 2025

Impact of culture dimensionality and matrix composition on morphology, phenotype and drug response in pancreatic cancer models.

Impact of culture dimensionality and matrix composition on morphology, phenotype and drug response in pancreatic cancer models.

Journal: Scientific reports
Published: August 14, 2025

Multi-drug pharmacotyping improves therapy prediction in pancreatic cancer organoids.

Multi-drug pharmacotyping improves therapy prediction in pancreatic cancer organoids.

Journal: Cancer cell international
Published: October 21, 2024

Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients-A Single Center Analysis of 2323 Patients within the Last Decade.

Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients-A Single Center Analysis of 2323 Patients within the Last Decade.

Journal: Journal of clinical medicine
Published: March 13, 2023

Inflammation-Based Prognostic Scores in Pancreatic Cancer Patients-A Single-Center Analysis of 1294 Patients within the Last Decade.

Inflammation-Based Prognostic Scores in Pancreatic Cancer Patients-A Single-Center Analysis of 1294 Patients within the Last Decade.

Journal: Cancers
Published: March 06, 2023

NeoRAS wild-type in metastatic colorectal cancer: Myth or truth?-Case series and review of the literature.

NeoRAS wild-type in metastatic colorectal cancer: Myth or truth?-Case series and review of the literature.

Journal: European journal of cancer (Oxford, England : 1990)
Published: March 09, 2021

Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer.

Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer.

Journal: Cell death & disease
Published: June 10, 2020

ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer.

ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer.

Journal: ESMO open
Published: May 06, 2020

Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis.

Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis.

Journal: International journal of cancer
Published: November 23, 2019
Showing 1-12 of 29

Last Updated: 09/26/2026